...
首页> 外文期刊>Transplant immunology >In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.
【24h】

In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.

机译:同种异体细胞毒性T淋巴细胞的体外反应性不能解释禁忌现象。

获取原文
获取原文并翻译 | 示例

摘要

Matching for human leucocyte antigens (HLA) is important for graft survival in kidney transplantation. Nevertheless, most patients receive a kidney graft with multiple HLA mismatches. Some of these mismatches seem to be more harmful than others. By studying the effect of single HLA mismatches in the context of the patients' own HLA, we have previously identified donor/recipient combinations with a significantly higher incidence of early graft failure, the so-called taboo combinations. In the present study we investigated whether a higher cytotoxic T lymphocyte (CTL) response towards taboo mismatches may be involved in this phenomenon. CTL reactivity was determined both in taboo and control combinations by in vitro CTL precursor assays, using peripheral blood mononuclear cells and proximal tubular epithelial cells as target cells. Inhibition studies with CD8-antibody as well as Cyclosporin A were performed to identify high avidity and primed CTLs. Furthermore, in committed CTLp assays indirect recognition of the taboo mismatch was tested using synthetic peptides. The CTL precursor frequencies in taboo combinations were always lower than the CTL precursor frequencies in control combinations. No difference in avidity and activation status of the CTLs could be detected when taboo combinations were compared with the controls. In the committed CTLp assays no reactivity towards any of the synthetic peptides was observed. The significantly poorer graft survival of taboo combinations cannot be explained by a higher number of donor-specific CTLs. Furthermore, the avidity or activation status of these CTLs does not provide a clue to the taboo phenomenon.
机译:匹配人类白细胞抗原(HLA)对于肾脏移植中的移植物存活至关重要。尽管如此,大多数患者还是接受了多个HLA不匹配的肾移植手术。这些不匹配中的某些似乎比其他不匹配更有害。通过研究患者自身HLA情况下单个HLA错配的影响,我们先前已经确定了早期移植失败的发生率明显更高的供体/受体组合,即所谓的禁忌组合。在本研究中,我们调查了对禁忌错配的更高细胞毒性T淋巴细胞(CTL)反应是否可能与这种现象有关。通过使用外周血单核细胞和近端肾小管上皮细胞作为靶细胞,通过体外CTL前体测定,在禁忌和对照组合中均确定了CTL反应性。进行了CD8抗体和环孢菌素A的抑制研究,以鉴定高亲和力和引发的CTL。此外,在定型CTLp分析中,使用合成肽测试了禁忌错配的间接识别。禁忌组合中的CTL前体频率始终低于对照组合中的CTL前体频率。当将禁忌组合与对照进行比较时,无法检测到CTL的亲和力和激活状态的差异。在定型CTLp测定中,未观察到对任何合成肽的反应性。禁忌组合的移植物存活率明显较差,这不能用更高数量的供体特异性CTL来解释。此外,这些CTL的亲和力或激活状态无法提供有关禁忌现象的线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号